Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guideline tyranny: a response to the article by Baum and Kaltsas.
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell D, Dean N, Dowell S, File T, Musher D, Niederman M, Torres A, Whitney C, Fine M; IDSA/ATS Guidelines Committee for Community-Acquired Pneumonia. Mandell L, et al. Among authors: wunderink r. Clin Infect Dis. 2008 Oct 15;47(8):1117-8. doi: 10.1086/592385. Clin Infect Dis. 2008. PMID: 18800941 No abstract available.
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S. Abraham E, et al. Among authors: wunderink r. Lancet. 1998 Mar 28;351(9107):929-33. Lancet. 1998. PMID: 9734938 Clinical Trial.
PATIENT EDUCATION INFORMATION SERIES. What is Pneumonia?
Jones B, Dean N, Wunderink R, Sockrider M. Jones B, et al. Among authors: wunderink r. Am J Respir Crit Care Med. 2016 Jan 1;193(1):P1-2. doi: 10.1164/rccm.1931P1. Am J Respir Crit Care Med. 2016. PMID: 26720793 No abstract available.
Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.
Bellingan G, Jacono F, Bannard-Smith J, Brealey D, Meyer N, Thickett D, Young D, Bentley A, McVerry BJ, Wunderink RG, Doerschug KC, Summers C, Rojas M, Ting A, Jenkins ED. Bellingan G, et al. Among authors: wunderink rg. Intensive Care Med. 2022 Jan;48(1):36-44. doi: 10.1007/s00134-021-06570-4. Epub 2021 Nov 23. Intensive Care Med. 2022. PMID: 34811567 Free PMC article. Clinical Trial.
400 results